Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records

Overview of attention for article published in Neuropsychopharmacology, February 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 39 news outlets
blogs: 6 blogs
twitter: 16 X users

reddit: 6 Redditors
bluesky: 5 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 6 Bluesky posts from 5 Bluesky users, with an upper bound of 7,712 followers.

Link to the original @npp-journal.bsky.social paper - led by Dr. Karl Karlsson of Reykjavik University - here: www.nature.com/articles/s41...

www.nature.com/articles/s41...

RP @sarahkmels.bsky.social: Potentially new indication for amlodipine; not just for blood pressure control- maybe for ADHD too, 👀🤔 www.nature.com/articles/s41...

Potentially new indication for amlodipine; not just for blood pressure control- maybe for ADHD too, 👀🤔 www.nature.com/articles/s41...

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 2 additional Bluesky posts.